The first, in the 1970s, was Pickarts discovery work: a factor in human plasma was identified that influenced the survival and growth behavior of cultured liver tissue, and Pickart and Thaler reported the responsible serum tripeptide
Sathyabhama M, Priya Dharshini LC, Karthikeyan A, Kalaiselvi S, Min T
Their clinical effects extend beyond weight loss, with evidence supporting their benefits on diabetes prevention, diabetes control, and improvement of cardiovascular disease and metabolic-associated steatotic liver disease (MASLD) outcomes
It has since been withdrawn from the list, pending a formal safety review
Fresh overnight culture of the diluted cells (~10 6 cells) as described above was inoculated to each GSH/antibiotic combination in the array